Abiopharma

AIXCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Strategic Real Estate Industry Engagement, Long-Term Infrastructure Direction, and Industry Signals From the Evolving AI Stack

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé au Japon comme premier médicament ciblé pour le traitement des adultes atteints de pemphigoïde bulleuse

Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved

Kulicke & Soffa Launches ASTERION™‑TW: Innovative Ultrasonic System Expands Power Assembly Portfolio

Yimutian Inc. to Acquire Ningbo Xunxi Technology for RMB 50 Million, Entering the Enterprise Digital Commerce Market

Apollo Funds Announce Strategic Investment in NSG Group, a Global Leader in Glass Manufacturing

Robbins LLP Urges BSX Stockholders Who Lost Money Investing in Boston Scientific Corporation to Contact the Firm for Information About Leading the Class Action

Robbins LLP Urges AQST Stockholders Who Lost Money Investing in Aquestive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action

Robbins LLP Urges EOSE Stockholders Who Lost Money Investing in Eos Energy Enterprises, Inc. to Contact the Firm for Information About Leading the Class Action